Showing 12,381 - 12,400 results of 106,501 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((nn decrease) OR (a decrease)) ))', query time: 1.58s Refine Results
  1. 12381
  2. 12382
  3. 12383
  4. 12384
  5. 12385
  6. 12386

    Table_1_Effectiveness of a program to lower unwanted media screens among 2–5-year-old children: a randomized controlled trial.docx by Nimran Kaur (11008865)

    Published 2024
    “…In the post-intervention assessment, 161 and 166 families continued while, at the follow-up assessment, 154 and 147 were in the intervention and control arm, respectively. The mean difference in ST on a typical day [27.7 min, 95% Confidence Interval (CI) 5.1, 50.3] at the post-intervention assessment significantly (p < 0.05) decreased in the intervention (102.6 ± 98.5 min) arm as compared with the control (130.3 ± 112.8 min) arm. …”
  7. 12387

    Table_1_Effectiveness of a program to lower unwanted media screens among 2–5-year-old children: a randomized controlled trial.docx by Nimran Kaur (11008865)

    Published 2024
    “…In the post-intervention assessment, 161 and 166 families continued while, at the follow-up assessment, 154 and 147 were in the intervention and control arm, respectively. The mean difference in ST on a typical day [27.7 min, 95% Confidence Interval (CI) 5.1, 50.3] at the post-intervention assessment significantly (p < 0.05) decreased in the intervention (102.6 ± 98.5 min) arm as compared with the control (130.3 ± 112.8 min) arm. …”
  8. 12388
  9. 12389
  10. 12390
  11. 12391
  12. 12392
  13. 12393

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…In this study, we report the first highly selective HDAC6 inhibitor with hydrazide as the zinc-binding group (ZBG), which displays superior pharmacokinetic properties to the current hydroxamic acid inhibitors. …”
  14. 12394

    Discovery of Triazolyl Derivatives of Cucurbitacin B Targeting IGF2BP1 against Non-Small Cell Lung Cancer by Fan-Fan Shang (16953264)

    Published 2023
    “…Cucurbitacin B (CuB) is a potent but toxic anticancer natural product. Herein, we designed and synthesized 2-OH- and 16-OH-modified CuB derivatives to improve their antitumor efficacy and reduce toxicity. …”
  15. 12395

    First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation by Kairui Yue (11874403)

    Published 2022
    “…In this study, we report the first highly selective HDAC6 inhibitor with hydrazide as the zinc-binding group (ZBG), which displays superior pharmacokinetic properties to the current hydroxamic acid inhibitors. …”
  16. 12396

    Deseasonalized anomaly time series of temperature ((a), (b)) and precipitation minus evaporation (<em>P</em> − <em>E</em>) changes over the tropical oceans and the tropical land fo... by Chunlei Liu (57542)

    Published 2013
    “…Anomalies are calculated with respect to the 1860–1950 period for CMIP5 historical data, 1961–1990 for HadCRUT4 and 1988–2005 for AMIP5 data sets; HadCRUT4 and AMIP anomalies are adjusted to agree with the CMIP5 ensemble mean over the period 1988–2005. …”
  17. 12397
  18. 12398
  19. 12399
  20. 12400

    MG-suppressed cell proliferation in a xenotransplantation model. by Chien-Yu Huang (802982)

    Published 2021
    “…Fluorescence labeled Hep3B and HepJ5 cells were implanted into an embryo yolk of the zebrafish, and then embryos were exposed to 40 μg/ml MG or dH<sub>2</sub>O as a vehicle control. …”